期刊文献+

TAM对人肝癌细胞增殖及ER表达的影响 被引量:2

Effects of tamoxifen on proliferation and ER expression of human hepatocellular carcinoma cells
下载PDF
导出
摘要 目的研究他莫昔芬(TAM)对人肝癌HepG2细胞增殖和雌激素受体(ER)表达的影响。方法将7.5、15、30μmol/L的TAM分别作用于HepG2细胞(观察组),对照组不加TAM,每孔加入1×105/ml细胞0.1 ml,培养24、48、72 h,采用MTT法测定HepG2抑制率;细胞免疫组化染色观察HepG2细胞ER的表达。结果TAM作用后HepG2细胞增殖随浓度增加及处理时间延长,细胞抑制率增加。结论TAM可抑制肝癌细胞增殖,其机理可能为降低ER表达。 [ Objective] To study effects of tamoxifen on proliferation and estrogen(ER) expression of human hepatoeellular carcinoma HepG2 cells. [ Methods] HepG2 cells were treated with tamoxifen, at concentration of 7.5 μmol/L, 15 μmol/L and 30 μmol/L, control group wasnt treated with tamoxifen. Then the cells were cultured for 24 h,48 h and 72 h respectively. MTY was used to determine suppression rate of HepG2 cells; cellular immunohistoehemistry was adopted to observe the effects of tamoxifen on ER expression of HepG2 cells. [ Results] Tamoxifen inhibited the proliferating rates of HepG2 cells in doesand time-dependent manner. Tamoxifen suppressed the ER expression of HepG2 cell in does- and time- dependent. [ Conclusions ] Tamoxffen can suppress human hepatocellular carcinoma HepG2 cells proliferation through inhibiting ER expression.
出处 《山东医药》 CAS 北大核心 2007年第26期10-11,共2页 Shandong Medical Journal
基金 山东省自然科学基金资助项目(Y2003C01)
关键词 肝肿瘤 HEPG2细胞 他莫昔芬 雌激素受体 carcinoma hepatoeellular tamoxifen estrogen receptor
  • 相关文献

参考文献6

  • 1Ln YS,Hsu C,Li CC,et al.Phase Ⅱ study of combination doxorubicin,interferon-alpha,and high-dose tamoxifen treatment for advanced hepatocellular carcinoma[J].Hepatogastroenterology,2004,51(57):815-819.
  • 2Waalkes MP,Liu J,Chen H,et al.Estrogen signaling in livers of male mice with hepatocellular carcinoma induced by exposure tp arsenic in utero[J].J Natl Cancer Inst,2004,96(6):466-474.
  • 3Marino M,Distofano E,Caporali S,et al.beta-estradiol stimulation of DNAsynthesisrequires different PKC isoforms in HepG2 sad MCF7 cells[J].J Cell Physiol,2001,188(2):170-177.
  • 4Zhang CC,Shapiro DJ.Activation of the p38 mltogen-activated protein kinase pathway by estrogen or by 4-hydmxytamoxifen is coupled to estrogen receptor-induced apoptosis[J].J Bid Chem,2000,275(1):479-486.
  • 5Liang Y,Hou M,Kallab AM.Induction of antiproliferation and apoptosis in estrogen receptor negative MDA-231 human breast cancer cells by mifepristone and 4-hydroxytamoxifen combination therapy:a role for TGFbetal[J].Int J Oncol,2003,23(2):369-380.
  • 6Riss TL,Moravec RA.Use of multiple assay endpoints to investigate the effects of incubation time,dose of toxin,and plating density in cell-based cytotoxicity assays[J].Assay Drug Dev Technol,2004,2(1):51-62.

同被引文献21

  • 1刘政,季国忠,缪林,杨春,张平.人肝癌及癌旁组织中Smad4、Smad7mRNA和蛋白表达研究[J].天津医药,2004,32(12):721-723. 被引量:13
  • 2阮潇舒,秦仁义.选择性Cox-2抑制剂Celebrex对人胆囊癌GBC-SD细胞系生长的抑制作用[J].中国普通外科杂志,2006,15(5):365-368. 被引量:2
  • 3胡珊珊,申秀英,许晓路.双酚A的毒理学效应及其作用机制的研究进展[J].江西科学,2006,24(5):383-386. 被引量:19
  • 4白文坤,王文奇,时昌文,吴洪文.他莫昔芬对人肝癌细胞增殖及ER、Smad4表达的影响[J].山东大学学报(医学版),2007,45(6):573-576. 被引量:3
  • 5黄晔.NP、BPA和B[a]P联合暴露对斑马鱼(Danioredo)体内雌激素/抗雌激素效应的研究[M].上海:华东师范大学,2008.
  • 6Leusch F D L,Vanden Heuvel M R, Laurie A D, et al. Quantifica- tion of vitellogenin mRNA induction in mosquitofish ( C, ambus/a afrO- n/s) by reverse transcription real-time polymerase chain reaction (RT-PCR) [J]. Biomarkers, 2005, 10(6): 429-438.
  • 7江艳艳,罗晓星,赵德化,等.苯并[a]芘对人胎盘绒毛膜上皮细胞中细胞色素P4501A1表达的诱导作用[J].研究快报,1999:1000-279006.S11.S12.
  • 8Fertuck K C, Matthews J B, Zacharewski T R. Hydroxylated benzo (a) pyrene metabolites are responsible for in vitro estrogen receptor- mediated gene expression induced by benzo(a) pyrene, but do not e- licit uterotrophic effects in vivo [J]. Toxicol Sci, 2001, 59:231 - 240.
  • 9van Lipzig M M, Vermeulen N P, Gusinu R, et al. Formation of estrogenic metabolites of benzo[ a ] pyrene and chrysene by cyto- chrome }'450 activity and their combined and supra-maximal estro- genic activity [J]. Environ Toxicol Pharm, 2005, 19 (1): 41 - 45.
  • 10Shipley J M, Waxman D J. Aryl hydrocarbon receptor-independent activation of estrogen receptor dependent transcription by 3-methyl- cholanthrene [ J ]. Toxicology and Applied Pharmacology, 2006, 213:87 -97.

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部